Ocular Manifestations and Clinical Implications of Serum Immunoglobulin G4 Levels in Graves' Ophthalmopathy Patients

Ocul Immunol Inflamm. 2022 Apr 3;30(3):580-587. doi: 10.1080/09273948.2020.1826537. Epub 2020 Oct 15.

Abstract

Purpose: To investigate the association between serum immunoglobulin G4 (IgG4) levels and laboratorial parameters. Moreover, the ocular manifestations were compared in Graves' ophthalmopathy (GO) patients.

Methods: Fifty-seven GO patients and fifty sex- and age-matched euthyroid subjects were enrolled. Serum IgG4 and immunoglobulin G (IgG) levels, thyroid hormones and thyroid autoantibodies were measured in all participants. Ophthalmologic examinations were performed to GO patients.

Results: Serum IgG4 levels were increased in GO patients compared with euthyroid subjects (p<0.001). Multivariate analysis showed that TRAb levels were correlated with IgG4 levels in GO patients (β=1.45, p = 0.024). There were eight GO patients with IgG4 levels ≥ 135 mg/dL. They all had both eyelids swelling and the differences of HER were less than 2mm. Seven patients (7/8) showed bilateral symmetrical thickening of the extraocular muscles.

Conclusions: Bilateral symmetry of ocular manifestation was observed in GO patients with IgG4 levels ≥135 mg/dL. IgG4 levels may be helpful in monitoring GO and diagnosing a new subtype of GO.

Keywords: Graves’ ophthalmopathy; IgG4; TRAb; thyroid autoantibody.

MeSH terms

  • Autoantibodies*
  • Eye
  • Graves Ophthalmopathy* / diagnosis
  • Humans
  • Immunoglobulin G
  • Oculomotor Muscles

Substances

  • Autoantibodies
  • Immunoglobulin G